Kura Oncology, Inc. (KURA)
7.77
+0.34
(+4.58%)
USD |
NASDAQ |
Nov 13, 16:00
7.88
+0.11
(+1.42%)
After-Hours: 19:59
Kura Oncology Market Cap : 713.85M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 713.85M |
| November 12, 2026 | 682.62M |
| November 11, 2026 | 710.18M |
| November 10, 2026 | 695.48M |
| November 09, 2026 | 695.48M |
| November 06, 2026 | 667.92M |
| November 05, 2026 | 624.74M |
| November 04, 2026 | 676.94M |
| November 03, 2026 | 878.87M |
| November 02, 2026 | 870.86M |
| October 30, 2026 | 912.67M |
| October 29, 2026 | 939.35M |
| October 28, 2026 | 953.59M |
| October 27, 2026 | 880.64M |
| October 26, 2026 | 855.74M |
| October 23, 2026 | 854.85M |
| October 22, 2026 | 877.09M |
| October 21, 2026 | 878.87M |
| October 20, 2026 | 887.76M |
| October 19, 2026 | 832.61M |
| October 16, 2026 | 807.70M |
| October 15, 2026 | 862.85M |
| October 14, 2026 | 854.85M |
| October 13, 2026 | 874.42M |
| October 12, 2026 | 924.68M |
| Date | Value |
|---|---|
| October 09, 2026 | 942.91M |
| October 08, 2026 | 935.80M |
| October 07, 2026 | 949.14M |
| October 06, 2026 | 936.69M |
| October 05, 2026 | 944.69M |
| October 02, 2026 | 947.36M |
| October 01, 2026 | 947.36M |
| September 30, 2026 | 952.70M |
| September 29, 2026 | 961.15M |
| September 28, 2026 | 943.80M |
| September 25, 2026 | 957.14M |
| September 24, 2026 | 966.04M |
| September 23, 2026 | 982.05M |
| September 22, 2026 | 1.043B |
| September 21, 2026 | 1.032B |
| September 18, 2026 | 1.043B |
| September 17, 2026 | 1.043B |
| September 16, 2026 | 996.28M |
| September 15, 2026 | 1.005B |
| September 14, 2026 | 1.028B |
| September 11, 2026 | 1.013B |
| September 10, 2026 | 1.029B |
| September 09, 2026 | 1.075B |
| September 08, 2026 | 1.114B |
| September 04, 2026 | 1.179B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 157.56M |
| Capricor Therapeutics, Inc. | 554.06M |
| ACADIA Pharmaceuticals, Inc. | 3.240B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 179.48M |
Market Cap Related Metrics
| PS Ratio | 8.702 |
| PEG Ratio | -0.0712 |
| Price to Book Value | 39.75 |
| Price | 7.77 |
| Earnings Yield | -42.45% |
| PEGY Ratio | -0.0712 |